Zobrazeno 1 - 10
of 11
pro vyhledávání: '"ELKE HEITMANN"'
Autor:
Bruno Guerci, Francesco Giorgino, Hélène Sapin, Kristina Boye, Jérémie Lebrec, Marco Orsini Federici, Elke Heitmann, Anne Dib, Martin Füchtenbusch, Luis‐Emilio García‐Pérez
Publikováno v:
Diabetes, Obesity and Metabolism. 24:2373-2382
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7c8fbdd5e0814484d411df4b85cf94f
https://doi.org/10.1111/dom.14823
https://doi.org/10.1111/dom.14823
Autor:
Francesco Giorgino, Bruno Guerci, Luis-Emilio García-Pérez, Martin Füchtenbusch, Jeremie Lebrec, Marco Orsini Federici, Anne Dib, Elke Heitmann, Maria Yu, Kristina Boye
Publikováno v:
Diabetologie und Stoffwechsel.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16d569e8257d42fa4026f72f0be8df84
https://doi.org/10.1055/s-0043-1767871
https://doi.org/10.1055/s-0043-1767871
Autor:
Heike Jung, Sascha R. Tittel, Nanette C. Schloot, Elke Heitmann, Thorsten Otto, Jeremie Lebrec, Marianne Pavel, Stefanie Lanzinger
Publikováno v:
Diabetes, Obesity and Metabolism.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a03dd16bbe477c6d3c3e83fa8246f2a8
https://doi.org/10.1111/dom.15038
https://doi.org/10.1111/dom.15038
Autor:
Thorsten Otto, Joanna Diesing, Julia Borchert, Elke Heitmann, Nanette C. Schloot, Jeremie Lebrec, Dirk Müller‐Wieland, Dennis Haeckl
Publikováno v:
Diabetes, obesity and metabolism 25, 767-775 (2023). doi:10.1111/dom.14924
Diabetes, obesity and metabolism 25, 767-775 (2023). doi:10.1111/dom.14924
Published by Wiley-Blackwell, Oxford [u.a.]
Published by Wiley-Blackwell, Oxford [u.a.]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e08952680f62e151fc942b9f11aae354
https://pubmed.ncbi.nlm.nih.gov/36457132
https://pubmed.ncbi.nlm.nih.gov/36457132
Autor:
null Thorsten Otto, null Joanna Diesing, null Julia Borchert, null Elke Heitmann, null Nanette Schloot, null Jeremie Lebrec, null Dirk Müller‐Wieland, null Dennis Haeckl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a153d90474bb2e6e43e5c5ed18ec61ee
https://doi.org/10.1111/dom.14924/v2/response1
https://doi.org/10.1111/dom.14924/v2/response1
Autor:
Bruno, Guerci, Francesco, Giorgino, Hélène, Sapin, Kristina, Boye, Jérémie, Lebrec, Marco Orsini, Federici, Elke, Heitmann, Anne, Dib, Martin, Füchtenbusch, Luis-Emilio, García-Pérez
Publikováno v:
Diabetes, obesitymetabolism. 24(12)
The primary objective of the TROPHIES observational study is to estimate the duration of treatment on dulaglutide or liraglutide without a significant treatment change by 24 months in patients with type 2 diabetes (T2D) initiating their first injecta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2ad61c4515541a2e700d5dd3e4d25475
https://pubmed.ncbi.nlm.nih.gov/35876235
https://pubmed.ncbi.nlm.nih.gov/35876235
Autor:
BRUNO GUERCI, FRANCESCO GIORGINO, KRISTINA BOYE, MARTIN FUECHTENBUSCH, ELKE HEITMANN, JEREMIE LEBREC, ANNE DIB, MARCO ORSINI FEDERICI, MARIA YU, LUIS-EMILIO GARCIA-PEREZ
Publikováno v:
Diabetes. 71
TROPHIES was a 24-month, prospective, non-comparative, observational study in adult patients with T2D initiating their first injectable glucose-lowering treatment with once-weekly dulaglutide (DU; N=1,014) or once-daily liraglutide (LIRA; N=991) in F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b64a216d9eca0f53ff290145fe234612
https://doi.org/10.2337/db22-726-p
https://doi.org/10.2337/db22-726-p
Autor:
FRANCESCO GIORGINO, BRUNO GUERCI, LUIS-EMILIO GARCIA-PEREZ, MARTIN FUECHTENBUSCH, JEREMIE LEBREC, MARCO ORSINI FEDERICI, ANNE DIB, ELKE HEITMANN, MARIA YU, KRISTINA BOYE
Publikováno v:
Diabetes. 71
TROPHIES was a 24-month, prospective, non-comparative, observational study in adult patients with T2D initiating their first injectable glucose-lowering treatment with once-weekly dulaglutide (DU; N=1,014) or once-daily liraglutide (LIRA; N=991) in F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c39fe6c90eb45b6631c1d22d7a979258
https://doi.org/10.2337/db22-746-p
https://doi.org/10.2337/db22-746-p
Autor:
MARTIN FUECHTENBUSCH, BRUNO GUERCI, FRANCESCO GIORGINO, LUIS-EMILIO GARCIA-PEREZ, ELKE HEITMANN, JEREMIE LEBREC, ANNABEL BARRETT, ANNE DIB, MARCO ORSINI FEDERICI, KRISTINA BOYE
Publikováno v:
Diabetes. 71
Data on patient-reported outcome (PRO) measures in people living with T2D who initiate injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA) medication in routine clinical practice are limited. Here we present final PRO data from the TROPHIE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f5e8e06eb9893cb260968c41a07c9a2
https://doi.org/10.2337/db22-738-p
https://doi.org/10.2337/db22-738-p
Autor:
null Bruno Guerci, null Francesco Giorgino, null Hélène Sapin, null Kristina Boye, null Jérémie Lebrec, null Marco Orsini Federici, null Elke Heitmann, null Anne Dib, null Martin Füchtenbusch, null Luis‐Emilio García‐Pérez
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7074bb685d14026d33ff6aae63124b46
https://doi.org/10.1111/dom.14823/v2/response1
https://doi.org/10.1111/dom.14823/v2/response1